Basic Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jun 7, 2020; 26(21): 2792-2809
Published online Jun 7, 2020. doi: 10.3748/wjg.v26.i21.2792
Table 4 Percentage reduction of the mean relative tumor area
No. of casek vs FOLFOXIRI (%)k vs GEMOX (%)k vs Gem/nab-P (%)k vs Gemcitabine (%)
1-74-59-67-60
2-62-40-73-15
3-69-6-27-58
4-412410-37
5-4-28-34-46
6-66-32-46-20
7-23-20-44-56
8-6047-30
9-56-74-62-41
10-45-1-55-51
11-55-55-46-49
12-38-491-21
13-49-51-29-23
1434-306932
1554-8-38-14